Recent Patents on Anti-Cancer Drug Discovery

SJR Rank #9,265H-index: 55SJR: 0.635Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Bentham Science Publishers

Country

United Arab Emirates

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Drug DiscoveryQ2
  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2
  • Cancer ResearchQ3
  • OncologyQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Diverse Scientific and Economic StudiesLegal Cases and CommentaryIntellectual Property and PatentsCancer Mechanisms and TherapyFerroptosis and cancer prognosisCancer, Hypoxia, and MetabolismCancer Research and TreatmentCancer Research and TreatmentsNanoparticle-Based Drug Delivery14-3-3 protein interactions

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

202220250255075100

Detailed Information

ISSN

1574-8928, 2212-3970

SJR Best Quartile

Q2

Region

Middle East

Citations per Document (2 years)

3.08

References per Document

72.65

Coverage

2006-2026

Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Metrics from SCImago Journal Rank 2025. View on SCImago